Edgewell Personal Care financials
$27.50−2.79%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Sep 30 | FY24 Sep 30 | FY23 Sep 30 | FY22 Sep 30 | FY21 Sep 30 | FY20 Sep 30 | FY19 Sep 30 | FY18 Sep 30 | FY17 Sep 30 | FY16 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.22B | $2.25B | $2.25B | $2.17B | $2.09B | $1.95B | $2.14B | $2.23B | $2.30B | $2.36B |
| Gross profit | $924.9M | $955.7M | $940.8M | $880.5M | $951.2M | $880.9M | $966.6M | $1.03B | $1.13B | $1.16B |
| Gross margin | 41.6% | 42.4% | 41.8% | 40.5% | 45.6% | 45.2% | 45.1% | 46.2% | 49.0% | 49.1% |
| Operating income | $96.6M | $199.3M | $227.0M | $182.3M | $239.9M | $176.0M | -$326.2M | $215.1M | -$1.1M | $295.1M |
| Net income | $25.4M | $98.6M | $114.7M | $99.5M | $117.8M | $67.6M | -$372.2M | $103.3M | $5.7M | $178.7M |
| Net margin | 1.1% | 4.4% | 5.1% | 4.6% | 5.6% | 3.5% | −17.4% | 4.6% | 0.2% | 7.6% |
| Diluted EPS | $0.53 | $1.97 | $2.21 | $1.85 | $2.13 | $1.24 | $-6.88 | $1.90 | $0.10 | $2.99 |
| EBITDA | $284.4M | $323.2M | $335.0M | $287.5M | $347.8M | $289.4M | $384.0M | $381.0M | $441.9M | $431.2M |
| Operating cash flow | $118.4M | $231.0M | $216.1M | $102.0M | $229.0M | $232.6M | $190.6M | $259.4M | $313.6M | $186.8M |
| Free cash flow | $41.4M | $174.5M | $166.6M | $45.6M | $172.2M | $184.9M | $132.6M | $197.4M | $244.6M | $117.3M |
| Diluted shares | 47.6M | 50.1M | 51.8M | 53.6M | 55.2M | 54.6M | 54.1M | 54.5M | 57.5M | 59.7M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $225.7M | $209.1M | $216.4M | $188.7M | $479.2M | $364.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $1.41B | $1.30B | $1.38B | $1.41B | $1.26B | $1.26B |
| Total assets | $3.76B | $3.73B | $3.74B | $3.71B | $3.67B | $3.54B |
| Total liabilities | $2.20B | $2.15B | $2.20B | $2.25B | $2.09B | $2.11B |
| Shareholders' equity | $1.55B | $1.58B | $1.54B | $1.47B | $1.58B | $1.43B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology